Registered Trials

• NCT04864561

  Phase 3

  United Kingdom of Great Britain and Northern Ireland

  Total Enrollment: 4,000

  Official Trial Registration:

  • NCT04864561(Opens in new tab/window)

• NCT04800133

  Phase 3

  Hong Kong

  Total Enrollment: 900

  Official Trial Registration:

  • NCT04800133(Opens in new tab/window)

• ISRCTN89951424, NCT04536051

  Phase 3

  Brazil

  Total Enrollment: 10,300

  Official Trial Registration:

  • ISRCTN89951424(Opens in new tab/window)
  • NCT04536051(Opens in new tab/window)

• NCT04516746

  Phase 3

  Argentina, Chile, Colombia, Peru, United States of America

  Total Enrollment: 32,459

  Official Trial Registration:

  • NCT04516746(Opens in new tab/window)

• NCT04540393

  Phase 3

  Russian Federation

  Total Enrollment: 100

  Official Trial Registration:

  • NCT04540393(Opens in new tab/window)

• CTRI/2020/08/027170

  Phase 2/3

  India

  Total Enrollment: 1,600

  Official Trial Registration:

  • CTRI/2020/08/027170(Opens in new tab/window)

• NCT04885764

  Phase 2/3

  Egypt

  Total Enrollment: 4,000

  Official Trial Registration:

  • NCT04885764(Opens in new tab/window)

• EUCTR2020-001228-32, NCT04400838

  Phase 2/3

  United Kingdom of Great Britain and Northern Ireland

  Total Enrollment: 12,390

  Official Trial Registration:

  • EUCTR2020-001228-32(Opens in new tab/window)
  • NCT04400838(Opens in new tab/window)

• ISRCTN73765130

  Phase 2

  United Kingdom of Great Britain and Northern Ireland

  Total Enrollment: 2,664

  Official Trial Registration:

  • ISRCTN73765130(Opens in new tab/window)

• NCT04894435

  Phase 2

  Canada

  Total Enrollment: 1,300

  Official Trial Registration:

  • NCT04894435(Opens in new tab/window)

• NCT04962906

  Phase 2

  Argentina

  Total Enrollment: 150

  Official Trial Registration:

  • NCT04962906(Opens in new tab/window)

• NCT04686773

  Phase 2

  Azerbaijan

  Total Enrollment: 100

  Official Trial Registration:

  • NCT04686773(Opens in new tab/window)

• NCT04907331

  Phase 2

  Austria

  Total Enrollment: 3,000

  Official Trial Registration:

  • NCT04907331(Opens in new tab/window)

• ISRCTN69254139

  Phase 2

  United Kingdom of Great Britain and Northern Ireland

  Total Enrollment: 820

  Official Trial Registration:

  • ISRCTN69254139(Opens in new tab/window)

• NCT04860739

  Phase 2

  Spain

  Total Enrollment: 676

  Official Trial Registration:

  • NCT04860739(Opens in new tab/window)

• EUCTR2021-001978-37

  Phase 2

  Spain

  Total Enrollment: 600

  Official Trial Registration:

  • EUCTR2021-001978-37(Opens in new tab/window)

• ISRCTN15638344

  Phase 2

  United Kingdom of Great Britain and Northern Ireland

  Total Enrollment: 300

  Official Trial Registration:

  • ISRCTN15638344(Opens in new tab/window)

• NCT04760730

  Phase 1/2

  Total Enrollment: 100

  Official Trial Registration:

  • NCT04760730(Opens in new tab/window)

• NCT04684446

  Phase 1/2

  Belarus, Russian Federation

  Total Enrollment: 100

  Official Trial Registration:

  • NCT04684446(Opens in new tab/window)

• NCT04568031

  Phase 1/2

  Japan

  Total Enrollment: 256

  Official Trial Registration:

  • NCT04568031(Opens in new tab/window)

• PACTR202005681895696

  Phase 1/2

  Kenya

  Total Enrollment: 400

  Official Trial Registration:

  • PACTR202005681895696(Opens in new tab/window)

• EUCTR2020-001072-15, NCT04324606

  Phase 1/2

  United Kingdom of Great Britain and Northern Ireland

  Total Enrollment: 1,112

  Official Trial Registration:

  • EUCTR2020-001072-15(Opens in new tab/window)
  • NCT04324606(Opens in new tab/window)

• PACTR202006922165132, NCT04444674

  Phase 1/2

  South Africa

  Total Enrollment: 2,130

  Official Trial Registration:

  • PACTR202006922165132(Opens in new tab/window)
  • NCT04444674(Opens in new tab/window)

• NCT04816019

  Phase 1

  United Kingdom of Great Britain and Northern Ireland

  Total Enrollment: 30

  Official Trial Registration:

  • NCT04816019(Opens in new tab/window)